ARA-290 is a non-erythropoietic analogue of erythropoietin (EPO) engineered to selectively engage the innate repair receptor (IRR) without activating the classical EPO receptor responsible for erythropoiesis. Published preclinical research has examined its cytoprotective signaling properties in inflammatory and ischemic tissue models, including modulation of NF-κB pathway activity and downstream cytokine expression in vitro. Studies have also characterized its interaction with the β-common receptor subunit in controlled in vivo animal model systems.
\n
Class: Non-Erythropoietic EPO Analogue / IRR Agonist | CAS: 1208243-50-8 | Purity: ≥98% (HPLC)
\n
Format: Lyophilized powder | Storage: −20°C, desiccated, protected from light
\n
\n
⚠️ Research Use Only. This compound is intended exclusively for qualified in vitro and laboratory research. It is not approved for human consumption, is not a dietary supplement, and has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or health condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws governing research chemical use.
